B
Baha Abdalhamid
Researcher at University of Nebraska Medical Center
Publications - 52
Citations - 1033
Baha Abdalhamid is an academic researcher from University of Nebraska Medical Center. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 15, co-authored 45 publications receiving 843 citations. Previous affiliations of Baha Abdalhamid include King Fahad Specialist Hospital & Creighton University.
Papers
More filters
Journal ArticleDOI
Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources.
Baha Abdalhamid,Christopher R. Bilder,Emily L. Mccutchen,Steven H. Hinrichs,Scott A. Koepsell,Peter C. Iwen +5 more
TL;DR: When the incidence rate of SARS-CoV-2 infection is 10% or less, group testing will result in the saving of reagents and personnel time with an overall increase in testing capability of at least 69%.
Journal ArticleDOI
Characterization of β-Lactamases Responsible for Resistance to Extended-Spectrum Cephalosporins in Escherichia coli and Salmonella enterica Strains from Food-Producing Animals in the United Kingdom
Ernesto Liebana,Matthew Gibbs,Carol Clouting,Leslie Barker,Felicity A. Clifton-Hadley,Eve Pleydell,Baha Abdalhamid,Nancy D. Hanson,Laura Martin,Cornelius Poppe,Robert Davies +10 more
TL;DR: The data imply that beta-lactam resistance in animal isolates can be generated de novo as evidenced by the E. coli strains, or in the case of the Salmonella strains be the result of intercontinental transmission due to an acquired resistance mechanism.
Journal ArticleDOI
Escherichia coli: Development of Carbapenem Resistance During Therapy
Tao Hong,Ellen Smith Moland,Baha Abdalhamid,Nancy D. Hanson,Jie Wang,Cindy Sloan,Diane Fabian,Awny Farajallah,Jerome Levine,Kenneth S. Thomson +9 more
TL;DR: This is the first documented case in which carbapenem-resistant E. coli emerged during therapy with imipenem and meropenem, and the first identification of the carbapanem-hydrolyzing enzyme in E. bacteria isolates.
Posted ContentDOI
Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources.
Baha Abdalhamid,Christopher R. Bilder,Emily L. Mccutchen,Steven H. Hinrichs,Scott A. Koepsell,Peter C. Iwen +5 more
TL;DR: Group testing will result in the saving of reagents and personnel time with an overall increase in testing capability of at least 69% when the incidence rate of SARS-CoV-2 infection is 10% or less.
Journal ArticleDOI
Molecular characterization of extended-spectrum beta-lactamase producing Enterobacteriaceae in a Saudi Arabian tertiary hospital
Hoda A. Hassan,Baha Abdalhamid +1 more
TL;DR: This study confirms a high level of blaCTX-M positive ESBL isolates are circulating in the Eastern Province of Saudi Arabia, and the trend of a multidrug-resistant profile associated with the recovery of the blaConnected X-M gene is alarming.